180 related articles for article (PubMed ID: 25728289)
1. Comparison between Ki-67 index and mitotic index for predicting outcome in canine mast cell tumours.
van Lelyveld S; Warland J; Miller R; Maw H; Foale R; Goodfellow M; Dobson J
J Small Anim Pract; 2015 May; 56(5):312-9. PubMed ID: 25728289
[TBL] [Abstract][Full Text] [Related]
2. Comparison of minichromosome maintenance protein 7, Ki67 and mitotic index in the prognosis of intermediate Patnaik grade cutaneous mast cell tumours in dogs.
Berlato D; Murphy S; Laberke S; Rasotto R
Vet Comp Oncol; 2018 Dec; 16(4):535-543. PubMed ID: 29989314
[TBL] [Abstract][Full Text] [Related]
3. Association of Ki67 index with prognosis for intermediate-grade canine cutaneous mast cell tumours.
Maglennon GA; Murphy S; Adams V; Miller J; Smith K; Blunden A; Scase TJ
Vet Comp Oncol; 2008 Dec; 6(4):268-74. PubMed ID: 19178685
[TBL] [Abstract][Full Text] [Related]
4. Comparison of mitotic index and Ki67 index in the prognostication of canine cutaneous mast cell tumours.
Berlato D; Murphy S; Monti P; Stewart J; Newton JR; Flindall A; Maglennon GA
Vet Comp Oncol; 2015 Jun; 13(2):143-50. PubMed ID: 23489679
[TBL] [Abstract][Full Text] [Related]
5. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
6. Canine subcutaneous mast cell tumour: diagnosis and prognosis.
Newman SJ; Mrkonjich L; Walker KK; Rohrbach BW
J Comp Pathol; 2007 May; 136(4):231-9. PubMed ID: 17399734
[TBL] [Abstract][Full Text] [Related]
7. The importance of the mitotic index as a prognostic factor for survival of canine cutaneous mast cell tumors: a validation study.
Elston LB; Sueiro FA; Cavalcanti JN; Metze K
Vet Pathol; 2009 Mar; 46(2):362-4, author reply 364-5. PubMed ID: 19261652
[No Abstract] [Full Text] [Related]
8. The value of immunohistochemical expression of BAX in formulating a prognosis for canine cutaneous mast cell tumours.
Strefezzi Rde F; Kleeb SR; Xavier JG; Fukumasu H; Catão-Dias JL
J Comp Pathol; 2012 May; 146(4):314-9. PubMed ID: 21899858
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Ki67, Bax, Bcl-2 and KIT in canine cutaneous mast cell tumours and their relationship with histopathology and prognosis.
Aytemiz Danyer I; Gürel A
Acta Vet Hung; 2024 Jan; 71(3-4):183-192. PubMed ID: 38112689
[TBL] [Abstract][Full Text] [Related]
10. Outcome of dogs with intermediate grade low mitotic index high Ki67 mast cell tumours treated with surgery and single agent lomustine.
Néčová S; Mason SL; North SM
Aust Vet J; 2021 May; 99(5):146-151. PubMed ID: 33565080
[TBL] [Abstract][Full Text] [Related]
11. Expression of Phosphorylated KIT in Canine Mast Cell Tumor.
Halsey CHC; Thamm DH; Weishaar KM; Burton JH; Charles JB; Gustafson DL; Avery AC; Ehrhart EJ
Vet Pathol; 2017 May; 54(3):387-394. PubMed ID: 28129097
[TBL] [Abstract][Full Text] [Related]
12. Recurrence rates and clinical outcome for dogs with grade II mast cell tumours with a low AgNOR count and Ki67 index treated with surgery alone.
Smith J; Kiupel M; Farrelly J; Cohen R; Olmsted G; Kirpensteijn J; Brocks B; Post G
Vet Comp Oncol; 2017 Mar; 15(1):36-45. PubMed ID: 25643820
[TBL] [Abstract][Full Text] [Related]
13. Mitotic index is predictive for survival for canine cutaneous mast cell tumors.
Romansik EM; Reilly CM; Kass PH; Moore PF; London CA
Vet Pathol; 2007 May; 44(3):335-41. PubMed ID: 17491075
[TBL] [Abstract][Full Text] [Related]
14. Expression of Fibroblast Activating Protein and Correlation with Histological Grade, Mitotic Index and Ki67 Expression in Canine Mast Cell Tumours.
Giuliano A; Dos Santos Horta R; Constantino-Casas F; Hoather T; Dobson J
J Comp Pathol; 2017 Jan; 156(1):14-20. PubMed ID: 27889201
[TBL] [Abstract][Full Text] [Related]
15. Investigating Associations Between Proliferation Indices, C-kit, and Lymph Node Stage in Canine Mast Cell Tumors.
Krick EL; Kiupel M; Durham AC; Thaiwong T; Brown DC; Sorenmo KU
J Am Anim Hosp Assoc; 2017; 53(5):258-264. PubMed ID: 28792799
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 protein expression and tumor associated inflammatory cells (macrophages and mast cells) in canine colorectal carcinoma.
Woldemeskel M; Hawkins I; Whittington L
BMC Vet Res; 2017 Apr; 13(1):111. PubMed ID: 28427401
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic intrinsic pathway proteins predict survival in canine cutaneous mast cell tumours.
Barra CN; Macedo BM; Cadrobbi KG; Pulz LH; Huete GC; Kleeb SR; Xavier JG; Catão-Dias JL; Nishiya AT; Fukumasu H; Strefezzi RF
Vet Comp Oncol; 2018 Mar; 16(1):E38-E44. PubMed ID: 28608404
[TBL] [Abstract][Full Text] [Related]
18. Prognostic evaluation of Ki67 threshold value in canine oral melanoma.
Bergin IL; Smedley RC; Esplin DG; Spangler WL; Kiupel M
Vet Pathol; 2011 Jan; 48(1):41-53. PubMed ID: 21123859
[TBL] [Abstract][Full Text] [Related]
19. High COX-2 expression in canine mast cell tumours is associated with proliferation, angiogenesis and decreased overall survival.
Gregório H; Raposo T; Queiroga FL; Pires I; Pena L; Prada J
Vet Comp Oncol; 2017 Dec; 15(4):1382-1392. PubMed ID: 28467670
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic impact of regional lymphadenectomy in canine stage II cutaneous mast cell tumours.
Marconato L; Polton G; Stefanello D; Morello E; Ferrari R; Henriques J; Tortorella G; Benali SL; Bergottini R; Vasconi ME; Annoni M; Sabattini S
Vet Comp Oncol; 2018 Dec; 16(4):580-589. PubMed ID: 30047226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
